Cases involving a new COVID-19 variant – NB.1.8.1 – have been detected in the U.S. The variant is part of the Omicron strain, which means the currently approved vaccines should be effective.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
After creating antibody makers Apogee and Spyre, Paragon Therapeutics is back with another inflammatory and immune disease biotech, and the startup is immediately going to the public markets. Waltham, MA-based biologics maker Oruka Therapeutics, focused […]
LOUISVILLE, Colo.–(BUSINESS WIRE)–Sierra Space, a leading, pureplay commercial space company building the first end-to-end business and technology platform in space, announced today that the company will present at Jefferies Industrials Conference on Wednesday, September 6, […]
AdventHealth Avista’s plans for a new location have taken a step forward following a $34 million purchase of land within Redtail Ridge in Louisville. Click here to view original post Click Here to Publish/Feature Your […]
Copyright © 2026 Biotech Networks
